COMMUNIQUÉS West-GlobeNewswire

Sonoma Pharmaceuticals Appoints Phillipe Weigerstorfer to Board of Directors

19/09/2018 - 13:05

PETALUMA, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced the appointment of Philippe Weigerstorfer to the company’s board of directors. Weigerstorfer brings [...]

BeyondSpring Strengthens Intellectual Property Portfolio with Newly Granted U.S. Patent for Plinabulin

19/09/2018 - 13:00

NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced today that the U.S. [...]

Ortho Regenerative Technologies Inc. Appoints Accomplished Life Science Executive, Luc Mainville, as CFO

19/09/2018 - 13:00

KIRKLAND, Quebec, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. (“Ortho RTi” or the “Corporation”) (CSE: ORTH) today announced the appointment of Luc Mainville as Senior Vice President and [...]

Four Ogilvy CommonHealth Worldwide executives tapped to serve as jurors for three premier industry award shows

19/09/2018 - 13:00

PARSIPPANY, N.J., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP, www.wpp.com ), announced four top executives from the [...]

Helius Announces First Partnership to Implement Clinical Experience Programs With the Investigational PoNS™ Therapy in the United States

19/09/2018 - 13:00

NEWTOWN, Pa., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that it has [...]

Axsome Therapeutics to Host R&D Day with Key Opinion Leaders Focused on AXS-05 and Unmet Needs in Alzheimer’s Disease Agitation

19/09/2018 - 13:00

NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

CNIB Foundation launches Phone It Forward

19/09/2018 - 12:30

Game-changing program accepts any modern smartphone to help people with sight loss TORONTO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The CNIB Foundation has announced the launch of its newest program, Phone It Forward, a [...]

La Fondation INCA lance « Rendre l’appareil »

19/09/2018 - 12:30

Ce programme change la donne en fournissant des téléphones intelligents remis à neuf à des personnes vivant avec une perte de vision TORONTO, 19 sept. 2018 (GLOBE NEWSWIRE) -- La Fondation INCA annonce le lancement de [...]

HEXO Awarded Three Year Distribution Contract for Quebec On-Line Cannabis Distribution, Selects Metro as Third-Party Logistics Partner

19/09/2018 - 12:30

GATINEAU, Quebec, Sept. 19, 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) and Metro Supply Chain Group Inc. (“Metro”) announced today that they have signed a contract to manage a warehouse and [...]

HEXO signe un contrat de trois ans pour la distribution de cannabis en ligne au Québec et choisit Metro comme partenaire de logistique tiers

19/09/2018 - 12:30

GATINEAU, Québec, 19 sept. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO) et Metro Supply Chain Group Inc. (« Metro ») ont annoncé aujourd’hui la signature d’un contrat de gestion d’un [...]

Neuronascent Awarded $2.25 Million NIH Grant to Develop a Regenerative Therapeutic for Alzheimer’s Disease

19/09/2018 - 12:00

CLARKSVILLE, Md., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced that the National Institute on Aging (NIA), part of the National [...]

Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) and TP-6076 Data at IDWeek 2018

19/09/2018 - 12:00

– Four Abstracts Selected for Poster Presentations – – TP-6076 Featured in Oral Presentation – WATERTOWN, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical [...]

Changes in responsibility areas of the Orion Group Executive Management Board

19/09/2018 - 10:46

ORION CORPORATION STOCK EXCHANGE RELEASE 19 SEPTEMBER 2018 at 11.45 a.m. EEST Changes in responsibility areas of the Orion Group Executive Management Board The following changes have been decided in responsibility areas [...]

APEIRON Announces Collaboration with Lead Discovery Center GmbH

19/09/2018 - 10:00

Alliance for medicinal chemistry optimization and development of novel checkpoint blockade approach VIENNA, Austria, Sept. 19, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, an Austrian company focused on cancer [...]

JSC Olainfarm attracts third Market Maker

19/09/2018 - 09:00

JSC Olainfarm announces that the Company has signed a Market Maker agreement with international investment company UAB “Orion Securities” thus joining few other Joint Stock companies in Baltics having three market [...]

LIDDS receives NanoZolid® technology patent protection until 2037

19/09/2018 - 08:30

The European Patent Office has approved a novel patent for LIDDS NanoZolid® technology. LIDDS patent protection for the drug delivery technology is now extended for at least another nineteen years. The new patent [...]

Solon Eiendom ASA – Primary insider notification

19/09/2018 - 08:30

(Oslo, Norway, September 18, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 20.000 shares in Solon Eiendom ASA at a price of NOK 29.017. Following [...]

Polydex Reports Second Quarter Financial Results

19/09/2018 - 08:12

Sales Remain Consistent, Profits Up TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) today announced financial results for the second quarter of the 2019 [...]

SPINEWAY : Souscription de 100 OCEANE

19/09/2018 - 08:01

Souscription de 100 obligations convertibles ou échangeables en actions nouvelles et/ou existantes (OCEANE) assorties de bons de souscription d'actions pour un montant nominal d'1 MEUR Spineway (la « Société ») annonce [...]